Home > > > Global Huber Needles Market: USD 44.34 Million in 2022 to USD 64.94 Million by 2029 at 5.6% CAGR.

Global Huber Needles Market: USD 44.34 Million in 2022 to USD 64.94 Million by 2029 at 5.6% CAGR.

Author : pratiksha mmr | Published On : 14 Aug 2026

Global Huber Needles Market: USD 44.34 Million in 2022 to USD 64.94 Million by 2029 at 5.6% CAGR.

The Global Huber Needles Market was valued at USD 44.34 million in 2022 and is projected to reach approximately USD 64.94 million by 2029, expanding at a 5.6% CAGR during 2023–2029. Rising cancer prevalence, increasing demand for chemotherapy, greater access to quality healthcare, medical tourism, chronic-disease management, and stronger patient-safety requirements are supporting sustained market expansion.

Huber needles are specialized non-coring needles designed for accessing implanted ports, particularly in oncology and long-term infusion therapies. Their role is expanding as healthcare providers prioritize safer vascular access, reliable drug administration, reduced tissue damage, and improved clinician handling. The market is therefore moving toward safety-oriented device innovation rather than competing solely on conventional needle design.

Request a Free Sample of Full Market Report Link: https://www.maximizemarketresearch.com/request-sample/146117/ 

Safety Innovation Reshapes the Next-Generation Medical Device Market

The future of the Huber Needles Market is being shaped by the convergence of patient comfort, healthcare-worker protection, device reliability, and regulatory compliance. Safety-engineered Huber needles are increasingly designed to reduce accidental needlestick injuries while maintaining efficient port access.

Vygon's current portfolio illustrates this innovation direction, with safety Huber needles featuring mechanisms intended to protect healthcare workers during withdrawal and disposal. Its portfolio includes Polyperf Safe, PPS Flow+, PPS CT, Perfusafe2, and Qimoperfusafe systems.

The industry's technology roadmap is also becoming more sophisticated. Devices increasingly emphasize positive-pressure locking, compatibility with high-pressure injections, visibility of the puncture site, ergonomic handling, and configurations suitable for different patient populations.

Get Free Sample  of Full Market Report Link: https://www.maximizemarketresearch.com/market-report/huber-needles-market/146117/ 

High-Opportunity Segments Shaping Market Growth

According to Maximize Market Research, the Huber Needles Market is segmented across three major dimensions:

  • By Type: Coring Huber Needle; Non-Coring Needle

  • By Application: Blood Transfusion; Application for Cancer; Parenteral Nutrition

  • By End User: Hospitals; Nursing Homes; Clinics; Ambulatory Surgical Centers

Non-coring Huber needles represent an important technology segment because their angled tip is designed to reduce the possibility of coring the implanted port's silicone septum. This design characteristic makes them particularly relevant for repeated access to implanted ports.

Among applications, blood transfusion represents a major demand area, while cancer treatment remains strategically important because Huber needles are extensively associated with chemotherapy and implanted-port access. Hospitals represent the leading end-user environment because of their larger patient volumes and concentration of oncology and infusion services.

Regulatory and Product Innovation Accelerate the Safety Agenda

Recent regulatory activity demonstrates continued innovation in the non-coring Huber needle category. In November 2024, the U.S. FDA granted 510(k) clearance to Bard Access Systems' PowerLoc Max Power Injectable Infusion Set; SafeStep Huber Needle Set.

The FDA subsequently recorded a 510(k) decision for Promisemed Safety Huber Needles in March 2025, highlighting continued product development and regulatory activity in the category.

BD's SafeStep Huber Needle Set emphasizes a compact design, rotating needle head, padded footprint, and an integrated safety mechanism designed to cover and lock the needle after removal.

Vygon is also advancing safety-focused vascular access with products designed around single-hand activation, positive-pressure locking, and protection against needlestick injuries. Its PPSCT system is designed for power injection and compatibility with contrast-agent administration.

These developments signal a broader industry transition toward smart safety engineering, ergonomic medical devices, standardized workflows, and integrated vascular-access solutions.

Regional Outlook: North America Leads as Asia-Pacific Accelerates

  • USA: North America dominated the Huber Needles Market with approximately 42% share in 2022. The region benefits from advanced healthcare infrastructure, significant chronic-disease burden, established medical-device markets, and demand for advanced patient-safety technologies.

  • UK: The UK is included within MMR's European country analysis, with opportunities spanning type, application, and end-user categories.

  • Germany: Germany remains an important European market within MMR's forecast structure, supported by established healthcare infrastructure and demand for medical devices.

  • Japan: Japan is covered as a key Asia-Pacific country market, offering opportunities across Huber needle types, applications, and healthcare settings.

  • South Korea: South Korea forms part of MMR's Asia-Pacific country analysis, positioning it within the region's expanding healthcare-device opportunity.

  • China: China represents a major Asia-Pacific market included in MMR's country-level assessment, with healthcare infrastructure expansion supporting long-term demand.

  • India: India is included in MMR's Asia-Pacific analysis and offers opportunities as healthcare access, oncology treatment, and medical-device adoption expand.

Asia-Pacific is expected to grow rapidly during the forecast period, supported by improving healthcare infrastructure and government support, while Middle East & Africa and South America also present emerging opportunities as adoption of innovative medical equipment increases.

Competitive Landscape

MMR identifies B. Braun Medical Inc., Exel International, Smith's Medical, Nipro Medical Corp., Baxter International Inc., Novo Nordisk, C.R. Bard, Thiebaud S.A.S., AngioDynamics, Vygon S.A., BD Company, Exelint International Co., Medsurg, Medtronic, Boston Scientific, Argon Medical Devices, Terumo Corporation, Hamilton Syringes, and Hi-Tech Medical Devices among the key companies operating in the market.

Competition is increasingly centered on safety mechanisms, product ergonomics, port compatibility, pressure-injection capabilities, portfolio breadth, and healthcare-provider support.

Future Outlook: Safety, Precision and Patient-Centric Vascular Access

The Global Huber Needles Market is positioned for steady expansion through 2029 as cancer care, infusion therapy, blood transfusion, and long-term vascular access continue to require reliable medical devices. The strongest opportunities will emerge around non-coring designs, safety-engineered systems, ergonomic devices, reduced needlestick exposure, and integrated port-access solutions.

For medical-device manufacturers, healthcare providers, investors, and strategic planners, understanding segment attractiveness and regional adoption will be essential to capturing the next wave of opportunity. Maximize Market Research provides market intelligence, competitive analysis, regional opportunity mapping, and strategic insights to help organizations evaluate investment priorities and navigate the evolving global Huber Needles industry.

Angiographic Catheters Market https://www.maximizemarketresearch.com/request-sample/13132/ 

Peptic Ulcer Market https://www.maximizemarketresearch.com/request-sample/71854/ 

Huber Needles Market https://www.maximizemarketresearch.com/request-sample/146117/ 

About Maximize Market Research 

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

2nd Floor, Navale IT Park Phase 3
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India
+91 9607365656
[email protected]